Medical devices with biointerface

Medical devices with biointerface engineering govern how a catheter, guidewire, stent or implant actually meets living tissue at the surface, rather than the device’s structural or electrical function itself. Formacoat launched HydroMark, its proprietary hydrophilic coating platform, at MD&M West in January 2026, positioning it as an independent alternative to OEMs and CMOs amid consolidation among coating suppliers, building on more than 25 years in medical device coating services. Biocoat continues to innovate with a non-PFAS lumen coating method and its HYDAK hydrophilic coating line for guidewires and peripheral vascular devices, responding to regulatory pressure to eliminate PFAS from medical surfaces. Integer Holdings closed its acquisition of Precision Coating in January 2025, adding proprietary GlideLine fluoropolymer coatings, MICRALOX anodic coatings and IonGuard technology to its portfolio, and showcased an expanded coatings and R&D capability spanning PTFE, hydrophilic, parylene and advanced surface-modification technologies at MD&M West 2026. Freudenberg Medical launched LUBRITEQ, a new high-performance hydrophilic coating solution, in February 2026. DSM Biomedical (dsm-firmenich Biomedical) entered a strategic innovation collaboration with China’s Peijia Medical in 2025 to develop polymer heart-valve materials using UHMWPE and thermoplastic polyurethane, and maintained an active EuroPCR 2026 presence. In China, Sino Medical Sciences Technology received NMPA registration for a new-generation drug-eluting coronary stent system in February 2026.

The key directions of medical devices with biointerface are:

1. Hydrophilic lubricious coatings (Hydrophilic Lubricious Coatings): low-friction surface treatments for catheters, guidewires and other intravascular devices, easing insertion and reducing tissue trauma — Formacoat’s HydroMark, Biocoat’s HYDAK, Freudenberg Medical’s LUBRITEQ.
2. Multi-modal surface coating platforms (Multi-Modal Surface Platforms): broad coating portfolios spanning PTFE, hydrophilic, parylene and anodic technologies, scaled through acquisition into full-service coating-as-a-service offerings — Integer Holdings.
3. Bioactive anticoagulant polymer coatings (Bioactive Polymer Coatings): biomaterial and coating chemistries engineered for anticoagulant, anti-inflammatory or pro-endothelialization function on implanted device surfaces — DSM Biomedical’s polymer heart-valve and vascular-stent coating work.
4. Drug-eluting stent coating systems (Drug-Eluting Stent Coatings): polymer coatings that deliver a therapeutic agent from a stent surface into the vessel wall — Sino Medical Sciences Technology’s NMPA-approved coronary system.

Sectoral value chain#

[biointerface coating chemistry design] ──> [coating process development/qualification] ──> [regulatory clearance (FDA/MDR/NMPA)]
                                                    │
                                       (OEM device integration)
                                                    │
                                                    ▼
[portfolio/platform expansion] <─── [clinical deployment] <─────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Hydrophilic lubricity chemistry (Hydrophilic Lubricious Coatings): surface treatments that create a slippery, low-friction layer on intravascular devices, reducing insertion force and tissue trauma.
• Multi-technology coating platforms (Multi-Modal Surface Platforms): integrated fluoropolymer, hydrophilic, parylene and anodic coating capabilities offered as a single supplier platform.
• Bioactive/anticoagulant surface functionalization (Bioactive Polymer Coatings): coatings engineered to actively modulate the biological response — inhibiting clotting or inflammation — at the device-tissue interface.

The stack applies surface-engineering chemistry to govern how a device’s surface interacts with blood and tissue — lubricity, thromboresistance, drug elution — independent of the device’s own structural function.

1. Hydrophilic lubricious coating chemistry (Hydrophilic Lubricious Coatings):
   • Formacoat’s HydroMark, Biocoat’s HYDAK and Freudenberg Medical’s LUBRITEQ each reduce catheter/guidewire insertion friction, with Biocoat’s non-PFAS lumen method addressing tightening PFAS regulation.
2. Multi-technology coating platforms (Multi-Modal Surface Platforms):
   • Integer Holdings’ GlideLine fluoropolymer, MICRALOX anodic and IonGuard coatings, scaled through the Precision Coating acquisition into a full-service surface-modification offering spanning PTFE, hydrophilic and parylene technologies.
3. Bioactive anticoagulant polymer coatings (Bioactive Polymer Coatings):
   • DSM Biomedical’s UHMWPE/thermoplastic-polyurethane polymer heart-valve materials, developed with Peijia Medical, and the broader dual-peptide anticoagulant/pro-endothelialization vascular stent coating research direction its materials feed into.
4. Drug-eluting stent coating systems (Drug-Eluting Stent Coatings):
   • Sino Medical Sciences Technology’s NMPA-approved drug-eluting coronary stent coating, developed for percutaneous coronary intervention.